open access

Vol 78, No 6 (2010)
REVIEWS
Published online: 2010-10-29
Submitted: 2013-02-22
Get Citation

Searching for genes influencing tobacco smoking susceptibility

Alicja Siemińska
Pneumonol Alergol Pol 2010;78(6):432-438.

open access

Vol 78, No 6 (2010)
REVIEWS
Published online: 2010-10-29
Submitted: 2013-02-22

Abstract

Numerous studies indicate genetical background of susceptibility to tobacco smoking. The current review presents new achievements and perspectives in searching for genes involved in tobacco smoking and dependence, which have been described in recent years as a result of the development of molecular techniques. It has been emphasized that tobacco smoking is a complex, polygenic behavior. Presence of multiple gene-gene and gene-environment interactions makes it difficult to find a strong genetic association. The causes of inconsistency in the results of candidate gene association studies, as well as the new perspectives in searching for genetic determinants of tobacco smoking, are also widely discussed. In particular, the focus is on the genome-wide association studies which allow the complex analysis of links between thousands of single nucleotide polymorphisms with smoking phenotypes.
Pneumonol. Alergol. Pol. 2010; 78, 6: 432-438

Abstract

Numerous studies indicate genetical background of susceptibility to tobacco smoking. The current review presents new achievements and perspectives in searching for genes involved in tobacco smoking and dependence, which have been described in recent years as a result of the development of molecular techniques. It has been emphasized that tobacco smoking is a complex, polygenic behavior. Presence of multiple gene-gene and gene-environment interactions makes it difficult to find a strong genetic association. The causes of inconsistency in the results of candidate gene association studies, as well as the new perspectives in searching for genetic determinants of tobacco smoking, are also widely discussed. In particular, the focus is on the genome-wide association studies which allow the complex analysis of links between thousands of single nucleotide polymorphisms with smoking phenotypes.
Pneumonol. Alergol. Pol. 2010; 78, 6: 432-438
Get Citation

Keywords

tobacco smoking; twin studies; linkage analysis; candidate genes; genome-wide association studies

About this article
Title

Searching for genes influencing tobacco smoking susceptibility

Journal

Advances in Respiratory Medicine

Issue

Vol 78, No 6 (2010)

Pages

432-438

Published online

2010-10-29

Bibliographic record

Pneumonol Alergol Pol 2010;78(6):432-438.

Keywords

tobacco smoking
twin studies
linkage analysis
candidate genes
genome-wide association studies

Authors

Alicja Siemińska

References (64)
  1. Kandel D, Chen K, Warner LA, et al. Prevalence and demographic correlates of symptoms of last year dependence on alcohol, nicotine, marijuana and cocaine in the U.S. population. Drug Alcohol Depend. 1997; 44(1): 11–29.
  2. Woody GE, Cottler LB, Cacciola J. Severity of dependence: data from the DSM-IV field trials. Addiction. 1993; 88(11): 1573–1579.
  3. Malin DH, Lake JR, Smith TD, et al. Rodent model of nicotine abstinence syndrome. Pharmacol Biochem Behav. 1992; 43(3): 779–784.
  4. Benowitz NL, Hall SM, Herning RI, et al. Smokers of low-yield cigarettes do not consume less nicotine. N Engl J Med. 1983; 309(3): 139–142.
  5. American Psychiatric Association.. Diagnostic and Statistical Manual of Mental Disorders. IV. American Psychiatric Association, Washington (DC) 1994.
  6. World Health Organization. International Statistical Classification of Diseases and Related Health Problems Geneva, 1992.
  7. Lairson DR, Harrist R, Martin DW, et al. Screening for patients with alcohol problems: severity in patients identified by the CAGE. J. Drug Educ. 1992; 22: 237.
  8. Miller NS. Nicotine addiction as a disease. In: Cocores JA. ed. The clinical management of nicotine dependence. New York, Springer-Verlag 1991: 66–69.
  9. Heatherton TF, Kozlowski LT, Frecker RC, et al. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991; 86(9): 1119–1127.
  10. Etter JF, Duc TV, Perneger TV. Validity of the Fagerström test for nicotine dependence and of the Heaviness of Smoking Index among relatively light smokers. Addiction. 1999; 94(2): 268–281.
  11. Piper ME, Piasecki TM, Federman EB, et al. A multiple motives approach to tobacco dependence: the Wisconsin Inventory of Smoking Dependence Motives (WISDM-68). J Consult Clin Psychol. 2004; 72(2): 139–154.
  12. Shiffman S, Waters A, Hickcox M. The nicotine dependence syndrome scale: a multidimensional measure of nicotine dependence. Nicotine Tob Res. 2004; 6(2): 327–348.
  13. A Clinical Practice Guideline for Treating Tobacco Use and Dependence: A US Public Health Service Report. JAMA: The Journal of the American Medical Association. 2000; 283(24): 3244–3254.
  14. Clark DB, Wood DS, Martin CS, et al. Multidimensional assessment of nicotine dependence in adolescents. Drug Alcohol Depend. 2005; 77(3): 235–242.
  15. Wheeler KC, Fletcher KE, Wellman RJ, et al. Screening adolescents for nicotine dependence: the Hooked On Nicotine Checklist. J Adolesc Health. 2004; 35(3): 225–230.
  16. Huang CL, Cheng CP, Lin HH, et al. Psychometric testing of the Chinese version of the Hooked on Nicotine Checklist in adolescents. J Adolesc Health. 2009; 45(3): 281–285.
  17. Post A, Gilljam H, Rosendahl I, et al. Symptoms of nicotine dependence in a cohort of Swedish youths: a comparison between smokers, smokeless tobacco users and dual tobacco users. Addiction. 2010; 105(4): 740–746.
  18. DiFranza JR. Implications of the autonomy theory of nicotine dependence. MedGenMed. 2002; 4(3): 8.
  19. DiFranza JR, Savageau JA, Fletcher K, et al. Measuring the loss of autonomy over nicotine use in adolescents: the DANDY (Development and Assessment of Nicotine Dependence in Youths) study. Arch Pediatr Adolesc Med. 2002; 156(4): 397–403.
  20. DiFranza JR, Savageau JA, Fletcher K, et al. Symptoms of tobacco dependence after brief intermittent use: the Development and Assessment of Nicotine Dependence in Youth-2 study. Arch Pediatr Adolesc Med. 2007; 161(7): 704–710.
  21. DiFranza JR, Riggs N, Ann Pentz M. Time to re-examine old definitions of nicotine dependence. Nicotine Tob Res. 2008; 10(6): 1109–1111.
  22. McNeill A, West R, Jarvis M, et al. Cigarette withdrawal symptoms in adolescent smokers. Psychopharmacology. 1986; 90(4): 533–536.
  23. Centers for Disease Control and Prevention (CDC). Reasons for tobacco use and symptoms of nicotine withdrawal among adolescent and young adult tobacco users--United States, 1993. MMWR Morb Mortal Wkly Rep. 1994; 43(41): 745–750.
  24. Scragg R, Wellman RJ, Laugesen M, et al. Diminished autonomy over tobacco can appear with the first cigarettes. Addict Behav. 2008; 33(5): 689–698.
  25. Savageau JA, Mowery PD, DiFranza JR. Symptoms of diminished autonomy over cigarettes with non-daily use. Int J Environ Res Public Health. 2009; 6(1): 25–35.
  26. Leventhal H, Cleary PD. The smoking problem: a review of the research and theory in behavioral risk modification. Psychol Bull. 1980; 88(2): 370–405.
  27. Henningfield JE, Benowitz NL, Slade J, et al. Reducing the addictiveness of cigarettes. Tobacco Control. 1998; 7(3): 281–293.
  28. Benowitz NL, Henningfield JE. Establishing a nicotine threshold for addiction. The implications for tobacco regulation. N Engl J Med. 1994; 331(2): 123–125.
  29. DiFranza JR, Rigotti NA, McNeill AD, et al. Initial symptoms of nicotine dependence in adolescents. Tob Control. 2000; 9(3): 313–319.
  30. Panday S, Reddy SP, Ruiter RAC, et al. Nicotine dependence and withdrawal symptoms among occasional smokers. J Adolesc Health. 2007; 40(2): 144–150.
  31. Riggs NR, Chou CP, Li C, et al. Adolescent to emerging adulthood smoking trajectories: when do smoking trajectories diverge, and do they predict early adulthood nicotine dependence? Nicotine Tob Res. 2007; 9(11): 1147–1154.
  32. Wellman RJ, DiFranza JR, Pbert L, et al. A comparison of the psychometric properties of the hooked on nicotine checklist and the modified Fagerström tolerance questionnaire. Addict Behav. 2006; 31(3): 486–495.
  33. Fiore MC, Bailey WC, Cohen SJ. Treating tobacco use and dependence. Clinical practice guideline. Rockville M.D: U.S. Department of Health and Human Services. Public Health Service.
  34. Wellman RJ, Savageau JA, Godiwala S, et al. A comparison of the Hooked on Nicotine Checklist and the Fagerström Test for Nicotine Dependence in adult smokers. Nicotine Tob Res. 2006; 8(4): 575–580.
  35. DiFranza JR, Wellman RJ. A sensitization-homeostasis model of nicotine craving, withdrawal, and tolerance: integrating the clinical and basic science literature. Nicotine Tob Res. 2005; 7(1): 9–26.
  36. Kostowski W. Podstawowe mechanizmy i teorie uzależnień. Alkoholizm i Narkomania. 2006; 19: 139–168.
  37. Post R. Intermittent versus continuous stimulation: Effect of time interval on the development of sensitization or tolerance. Life Sciences. 1980; 26(16): 1275–1282.
  38. Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev. 1993; 18(3): 247–291.
  39. Robinson T, Berridge K. Incentive-sensitization and addiction. Addiction. 2001; 96(1): 103–114.
  40. Pert A, Post R, Weiss SR. Conditioning as a critical determinant of sensitization induced by psychomotor stimulants. NIDA Res Monogr. 1990; 97: 208–241.
  41. Robinson TE. Stimulant drugs and stress: factors influencing individual differences in the susceptibility to sensitization. In: Kalivas PW, Barnes C. ed. Sensitization in the nervous system. Caldwell N.J., Telford Press 1988: 145–173.
  42. OLDS J, MILNER P. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J Comp Physiol Psychol. 1954; 47(6): 419–427.
  43. Peciña S, Berridge KC, Parker LA. Pimozide does not shift palatability: separation of anhedonia from sensorimotor suppression by taste reactivity. Pharmacol Biochem Behav. 1997; 58(3): 801–811.
  44. McFarland K, Ettenberg A. Haloperidol differentially affects reinforcement and motivational processes in rats running an alley for intravenous heroin. Psychopharmacology (Berl). 1995; 122(4): 346–350.
  45. Kornetsky C. Brain-stimulation reward, morphine-induced oral stereotypy, and sensitization: implications for abuse. Neurosci Biobehav Rev. 2004; 27(8): 777–786.
  46. Epping-Jordan MP, Watkins SS, Koob GF, et al. Dramatic decreases in brain reward function during nicotine withdrawal. Nature. 1998; 393(6680): 76–79.
  47. Markou A, Koob GF, Markou A, et al. Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology. 1991; 4(1): 17–26.
  48. Volkow ND, Fowler JS, Wang GJ, et al. Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Neurobiol Learn Mem. 2002; 78(3): 610–624.
  49. Mackintosh NJ. The psychology of animal learning. Academic Press, London 1974.
  50. Di Chiara G. Drug addiction as dopamine-dependent associative learning disorder. Eur J Pharmacol. 1999; 375(1-3): 13–30.
  51. Ferrario CR, Gorny G, Crombag HS, et al. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur J Neurosci. 1999; 11(5): 1598–1604.
  52. Angrist B. Amphetamine psychosis: clinical variations of the syndrome. In: Cho AK, Segal DS. ed. Amphetamine and its analogs: Psychopharmacology, toxicology and abuse. Academic Press, New York 1994: 387–414.
  53. Strakowski SM, Sax KW. Progressive behavioral response to repeated d-amphetamine challenge: further evidence for sensitization in humans. Biol Psychiatry. 1998; 44(11): 1171–1177.
  54. Domino EF. Nicotine induced behavioral locomotor sensitization. Prog Neuropsychopharmacol Biol Psychiatry. 2001; 25(1): 59–71.
  55. Booze RM, Welch MA, Wood ML, et al. Behavioral sensitization following repeated intravenous nicotine administration: gender differences and gonadal hormones. Pharmacol Biochem Behav. 1999; 64(4): 827–839.
  56. Slotkin TA, Seidler FJ. Nicotine exposure in adolescence alters the response of serotonin systems to nicotine administered subsequently in adulthood. Dev Neurosci. 2009; 31(1-2): 58–70.
  57. Slotkin TA, Bodwell BE, Ryde IT, et al. Adolescent nicotine treatment changes the response of acetylcholine systems to subsequent nicotine administration in adulthood. Brain Res Bull. 2008; 76(1-2): 152–165.
  58. Slotkin TA, Ryde IT, Mackillop EA, et al. Adolescent nicotine administration changes the responses to nicotine given subsequently in adulthood: adenylyl cyclase cell signaling in brain regions during nicotine administration and withdrawal, and lasting effects. Brain Res Bull. 2008; 76(5): 522–530.
  59. Slotkin TA. Nicotine and the adolescent brain: insights from an animal model. Neurotoxicol Teratol. 2002; 24(3): 369–384.
  60. Hughes JR, Shiffman S. Conceptualizations of nicotine dependence: a response to DiFranza. Nicotine Tob Res. 2008; 10(12): 1811–1812.
  61. Difranza J. Smoking is not a mental illness. Expert Rev Respir Med. 2008; 2(4): 411–414.
  62. Hendricks PS, Prochaska JJ, Humfleet GL, et al. Evaluating the validities of different DSM-IV-based conceptual constructs of tobacco dependence. Addiction. 2008; 103(7): 1215–1223.
  63. Rose JS, Dierker LC. DSM-IV nicotine dependence symptom characteristics for recent-onset smokers. Nicotine Tob Res. 2010; 12(3): 278–286.
  64. DiFranza J, Ursprung WW, Lauzon B, et al. A systematic review of the Diagnostic and Statistical Manual diagnostic criteria for nicotine dependence. Addict Behav. 2010; 35(5): 373–382.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl